← Leaderboards
Gary B Baskin
Tulane University Of Louisiana
$798,496
Attributed
$798,496
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$798,496 · 7
By mechanism
R24$503,804 · 1
P51$294,692 · 6
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Rudolf P Bohm$51,450,972
- James L Blanchard$16,717,439
- Samir S El-Dahr$10,425,237
- Donald G Phinney$12,507,245
- Stryder Medoah Meadows$3,180,564
Others in their field
Top investigators on “Mammalia”
- James L. Weber · Marshfield Clinic Research Foundation$3,150,000
- Jon C Mirsalis · Sri International$2,790,741
- Scott C Weaver · University Of Texas Medical Br Galveston$2,490,681
- Ron C Orlando · University Of Georgia (Uga)$2,341,980
- Peter John Espenshade · University Of Texas Sw Med Ctr/Dallas$2,254,989
- Victor J Hruby · University Of Arizona$2,110,659
Research focus
MammaliaModel Design /DevelopmentGene TherapyTechnology /TechniqueInborn Metabolism DisorderCommunicable DiseasesCongenital DisordersVirusBacteriaBiotechnologyInflammationImmunologyLiverNervous SystemOrphan Disease /DrugRespiratory SystemDisease /Disorder ModelAidsKrabbe'S DiseaseProteinsLymphatic SystemMacaca MulattaMagnetic Resonance ImagingAssistive Reproductive Technique
Grant awards (11)
IMMUNOSUPPRESSION IN PROLONGING TRANSGENE EXPRESSION: CYSTIC FIBROSIS$0
P51 · FY2002 · RR
DEVELOPMENT OF RHESUS MODEL FOR HCV INFECTION: HEPATITIS$0
P51 · FY2002 · RR
AAV AS VECTOR FOR TREATMENT OF GLOBOID CELL LEUKODYSTROPHY$0
P51 · FY2002 · RR
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS: LYSOSOMAL STORAGE$0
P51 · FY2002 · RR
IMMUNOSUPPRESSION IN PROLONGING TRANSGENE EXPRESSION: CYSTIC FIBROSIS$0
P51 · FY2001 · RR
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS: LYSOSOMAL STORAGE$0
P51 · FY2001 · RR
DEVELOPMENT OF RHESUS MODEL FOR HCV INFECTION: HEPATITIS$0
P51 · FY2001 · RR
AAV AS VECTOR FOR TREATMENT OF GLOBOID CELL LEUKODYSTROPHY$0
P51 · FY2001 · RR
ANIMAL MODEL FOR GENE THERAPY OF INHERITED DISORDERS$503,804
R24 · FY2000 · RR
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS$147,346
P51 · FY2000 · RR
AAV AS VECTOR FOR TREATMENT OF GLOBOID CELL LEUKODYSTROPHY$147,346
P51 · FY2000 · RR